Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
TAVR & PAD | FDA clears AI-powered imaging solution | Fertility treatments & heart health
Tuesday, February 7, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

TAVR and PAD: What cardiologists need to know

TAVR patients presenting with peripheral artery disease face significantly higher in-hospital risks, according to a new study published in Current Problems in Cardiology. 

READ MORE >
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Share on Twitter Share on Facebook Share on Linkedin

TAVR and PAD: What cardiologists need to know

Share on Twitter Share on Facebook Share on Linkedin
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
TAVR patients presenting with peripheral artery disease face significantly higher in-hospital risks, according to a new study published in Current Problems in Cardiology. 
READ MORE >

FDA clears new AI-powered cardiac imaging solution

The newly approved software uses artificial intelligence to provide users with real-time feedback related to image quality.

READ MORE >
DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI-powered cardiac imaging solution

Share on Twitter Share on Facebook Share on Linkedin
DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images.
The newly approved software uses artificial intelligence to provide users with real-time feedback related to image quality.
READ MORE >

IVF, other fertility treatments do not put the heart health of children at risk

Parents who are currently considering the use of fertility treatments such as IVF may want to read this study closely. 

READ MORE >
ACR: FDA evidence backing thyroid monitoring in peds after ICM use is 'weak' #contrast #FDA #contrastshortage
Share on Twitter Share on Facebook Share on Linkedin

IVF, other fertility treatments do not put the heart health of children at risk

Share on Twitter Share on Facebook Share on Linkedin
ACR: FDA evidence backing thyroid monitoring in peds after ICM use is 'weak' #contrast #FDA #contrastshortage
Parents who are currently considering the use of fertility treatments such as IVF may want to read this study closely. 
READ MORE >

Featured Articles

AI model predicts risk of post-operative AFib

Post-operative atrial fibrillation was once viewed as a fairly insignificant issue, but more recent research suggests it can increase a patient’s risk of multiple adverse events. 

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

AI model predicts risk of post-operative AFib

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Post-operative atrial fibrillation was once viewed as a fairly insignificant issue, but more recent research suggests it can increase a patient’s risk of multiple adverse events. 
READ MORE >

VIDEO: Exploring the use of cerebral protection devices during TAVR

Samir Kapadia, MD, chair of the department of cardiovascular medicine at Cleveland Clinic, shared his perspective on the use of cerebral protection devices during TAVR procedures. 

READ MORE >
Samir Kapadia, MD, chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at Cleveland Clinic, explains why he believes the results of the late-breaking PROTECTED TAVR testing the use of a TAVR cerebral protection device were positive, although it did not meet its primary endpoint.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Exploring the use of cerebral protection devices during TAVR

Share on Twitter Share on Facebook Share on Linkedin
Samir Kapadia, MD, chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at Cleveland Clinic, explains why he believes the results of the late-breaking PROTECTED TAVR testing the use of a TAVR cerebral protection device were positive, although it did not meet its primary endpoint.
Samir Kapadia, MD, chair of the department of cardiovascular medicine at Cleveland Clinic, shared his perspective on the use of cerebral protection devices during TAVR procedures. 
READ MORE >

In Case You Missed It

VIDEO: Cardiologists share the latest details on COVID-related MIS-C

In this new video, pediatric cardiologists discuss some of the long-term issues associated with multisystem inflammatory syndrome in children (MIS-C), a rare disease linked to COVID-19.

READ MORE >
Nemours Children's Hospital pediatric cardiologists explain lessons learned about cardiac involvement and long-term issues from multisystem inflammatory syndrome in children (MIS-C), a rare but serious disease caused by exposure to the COVID-19 virus. #MIS-C #COVID #coronavirus #SARSCoV2
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Cardiologists share the latest details on COVID-related MIS-C

Share on Twitter Share on Facebook Share on Linkedin
Nemours Children's Hospital pediatric cardiologists explain lessons learned about cardiac involvement and long-term issues from multisystem inflammatory syndrome in children (MIS-C), a rare but serious disease caused by exposure to the COVID-19 virus. #MIS-C #COVID #coronavirus #SARSCoV2
In this new video, pediatric cardiologists discuss some of the long-term issues associated with multisystem inflammatory syndrome in children (MIS-C), a rare disease linked to COVID-19.
READ MORE >

FDA announces new IABP recall after 4 serious injuries, 1 death

The new recall includes nearly 4,500 devices. There have been 134 incidents so far, including 5 adverse events.  

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces new IABP recall after 4 serious injuries, 1 death

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The new recall includes nearly 4,500 devices. There have been 134 incidents so far, including 5 adverse events.  
READ MORE >

In Other News

Feds may block Amazon’s acquisition of One Medical

Amazon announced its intent to acquire One Medical in July 2022, and the $3.9 billion deal came under fire right away, with critics voicing their concerns about Amazon’s growing size and reach.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Feds may block Amazon’s acquisition of One Medical

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Amazon announced its intent to acquire One Medical in July 2022, and the $3.9 billion deal came under fire right away, with critics voicing their concerns about Amazon’s growing size and reach.
READ MORE >

FDA has now cleared more than 500 healthcare AI algorithms

More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.

READ MORE >
An example of artificial intelligence (AI) automated detection of a intracranial hemorrhage (ICH) in. a CT scan used to send alerts to the stroke acute care team before a radiologist even sees the exam. Example shown by TeraRecon at RSNA 2022.
Share on Twitter Share on Facebook Share on Linkedin

FDA has now cleared more than 500 healthcare AI algorithms

Share on Twitter Share on Facebook Share on Linkedin
An example of artificial intelligence (AI) automated detection of a intracranial hemorrhage (ICH) in. a CT scan used to send alerts to the stroke acute care team before a radiologist even sees the exam. Example shown by TeraRecon at RSNA 2022.
More than 500 clinical AI algorithms have now been cleared by the FDA, with the majority just in the past couple years.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme